SeekingAlpha · Sep 26, 2026
THQ: A 5.6% Cut Leaves An 11% Yield, But Payouts Now Follow NAV
Abrdn Healthcare Opportunities Fund (THQ) adopts a 10% variable distribution tied to NAV; assess payout sustainability, discount and leverageâread now.
TH
NYSE · THQ
Abrdn Healthcare Opportunities Fund
Financial Services · Asset Management
$17.53
Down-$0.22 (-1.24%)
Updated Oct 7, 2026, 8:59 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 771.31M
- P/E ratio
- 147.32
- Dividend yield
- 13.35%
- 52-week range
- $16.28 – $20.12
- Volume
- 168.53K
- Avg. volume
- 184.97K
Price performance · THQ
THQ price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
THQ closed at $17.53 after 21 trading sessions, down 9.83% for the selected period.
- Last close
- $17.53
- Period change
- -9.83%
- Period low
- $17.53
- Period high
- $19.44
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $17.81 | $17.90 | $17.48 | $17.53 | 168.53K |
| Oct 5, 2026 | $17.71 | $17.81 | $17.55 | $17.75 | 122.94K |
| Oct 2, 2026 | $18.00 | $18.00 | $17.78 | $17.78 | 176.92K |
| Oct 1, 2026 | $18.38 | $18.4699 | $17.84 | $17.85 | 164.85K |
| Sep 30, 2026 | $18.52 | $18.54 | $18.34 | $18.40 | 127.29K |
| Sep 29, 2026 | $18.57 | $18.57 | $18.15 | $18.32 | 169.24K |
| Sep 28, 2026 | $18.53 | $18.65 | $18.4201 | $18.49 | 179.47K |
| Sep 25, 2026 | $18.77 | $18.86 | $18.60 | $18.67 | 111.91K |
| Sep 24, 2026 | $18.86 | $18.95 | $18.66 | $18.76 | 103.97K |
| Sep 23, 2026 | $19.15 | $19.24 | $18.85 | $18.86 | 104.8K |
| Sep 22, 2026 | $19.14 | $19.2998 | $19.0138 | $19.24 | 106.42K |
| Sep 21, 2026 | $19.10 | $19.30 | $19.0213 | $19.26 | 122.7K |
| Sep 18, 2026 | $19.20 | $19.28 | $19.03 | $19.03 | 109.58K |
| Sep 17, 2026 | $19.10 | $19.2578 | $19.0536 | $19.21 | 94.73K |
| Sep 16, 2026 | $18.92 | $19.02 | $18.8519 | $18.91 | 70.43K |
| Sep 15, 2026 | $19.20 | $19.20 | $18.90 | $18.94 | 153.93K |
| Sep 14, 2026 | $19.07 | $19.3099 | $19.00 | $19.15 | 87.97K |
| Sep 11, 2026 | $19.01 | $19.26 | $18.8501 | $18.92 | 80.94K |
| Sep 10, 2026 | $19.30 | $19.30 | $18.91 | $18.91 | 107.3K |
| Sep 9, 2026 | $19.41 | $19.72 | $19.35 | $19.35 | 81.67K |
| Sep 8, 2026 | $19.66 | $19.6763 | $19.41 | $19.44 | 119.3K |
Latest THQ news
The latest Smart Investors Daily articles mentioning THQ.
Stock researchCompany · Overview
Company
Market Activity
Research & News
THQ research
Overview
Company profile and research snapshot.
Company profile
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Aug 27, 2026
THQ Offers High-Yield Income From Healthcare Stocks (Rating Upgrade)
abrdn Healthcare Opportunities Fund upgraded: 10.9% yield, -4.5% NAV discount, good distribution coverage and healthcare rebound potential. Click for a THQ update.
SeekingAlpha · Aug 26, 2026
abrdn Healthcare Opportunities Fund Q2 2026 Commentary
The equity portion of the abrdn Healthcare Opportunities Fund gained (gross of fees) and outperformed its benchmark.
SeekingAlpha · Aug 24, 2026
Healthcare Is Rising: XLV Is A Better Option For Investors Than BME
BMEâs gains stem from a shrinking NAV discount, not alpha.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
